Small-molecule inhibitors targeting TRMT61B’s methyltransferase activity could disrupt mitochondrial function and suppress tumor growth, but further studies are needed to evaluate their therapeutic efficacy. The gene discussed is TRMT61B; the disease is neoplasm.